Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Bulletin Du Cancer|January 1, 1989
[Diagnosis and treatment of unknown primary tumors]P Dodion, D De ValeriolaDrugs|September 1, 1997
Breast cancer therapies in development. A review of their pharmacology and clinical potentialD de Valeriola, A Awada, J A Roy, et al.Acta Oncologica (Stockholm, Sweden)|January 1, 1988
Phase I clinical trial of oral menogaril administered on three consecutive daysP Dodion, D de Valeriola, N Crespeigne, et al.European Journal of Cancer & Clinical Oncology|February 1, 1989
Phase I clinical trial with carbetimerP Dodion, D de Valeriola, J J Body, et al.Anti-Cancer Drugs|May 29, 2004
Prolonged schedule of temozolomide (Temodal) plus liposomal doxorubicin (Caelyx) in advanced solid cancersA Awada, T Gil, F Sales, et al.Cancer|December 15, 1988
Six-year results of a multimodality treatment strategy for locally advanced breast cancerM J Piccart, D de Valeriola, R Paridaens, et al.Breast (Edinburgh, Scotland)|September 29, 2005
Adjuvant chemotherapy in 2005: standards and beyondM J Piccart, D de Valeriola, L Dal Lago, et al.European Journal of Cancer & Clinical Oncology|June 1, 1988
Phase I clinical and pharmacokinetic trial of oral menogaril administered on three consecutive daysP Dodion, D de Valeriola, N Crespeigne, et al.British Journal of Cancer|May 5, 2005
Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumoursA Awada, A Hendlisz, T Gil, et al.Pageof 2